Erratum: Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1/2 and the downregulation of Akt (FEBS Letters (2006) 580 (703-710) DOI: 10.1016/j.febslet.2005.12.048);Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1/2 and the downregulation of Akt

FEBS Letters

Volumn 580, Issue 2, 2006, Pages 703-710

  Biswas, Kamal Krishna ^a   Tancharon, Salunya ^a   Sarker, Krishna Pada ^a,b   Kawahara, Ko Ichi ^a   Hashiguchi, Teruto ^a   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Apoptosis; Cepharanthine; MAPK; PARP; SP600125

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTIOXIDANT; CASPASE 3; CEPHARANTHINE; CYTOCHROME C; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

EID: 30644476699     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.01.067     Document Type: Erratum

References (44)

1. M. Tomita, K. Fujitani, and Y. Aoyagi Synthesis of di-cepharanthine Tetrahedron Lett. 13 1967 1201 1206
2. T. Kato, and Y. Suzumura Potentiation of antitumor activity of vincristine by biscoclaurine alkaloid cepharanthine J. Natl. Cancer Inst. 79 1987 527 532
3. M. Okamoto, M. Ono, and M. Baba Suppression of cytokine production and neural cell death by the anti-inflammatory alkaloid cepharanthine: a potential agent against HIV-1 encephalopathy Biochem. Pharmacol. 62 2001 747 753
4. K. Murakami, K. Okajima, and M. Uchiba The prevention of lipopolysaccharide-induced pulmonary vascular injury by pretreatment with cepharanthine in rats Am. J. Respir. Crit. Care Med. 161 2000 57 63
5. M. Goto, W.P. Zeller, and R.M. Hurley Cepharanthine (biscoclaurine alkaloid) treatment in endotoxic shock of suckling rats J. Pharm. Pharmacol. 43 1991 589 591
6. N. Shiraishi, S. Akiyama, M. Nakagawa, M. Kobayashi, and M. Kuwano Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells Cancer Res. 47 1987 2413 2416
7. J. Asaumi, K. Nishikawa, H. Matsuoka, M. Iwata, S. Kawasaki, Y. Hiraki, and K. Nishijima Direct antitumor effect of cepharanthine and combined effect with adriamycin against Ehrlich ascites tumor in mice Anticancer Res. 15 1995 67 70
8. J. Wu, H. Suzuki, A.A. Akhand, Y.W. Zhou, K. Hossain, and I. Nakashima Modes of activation of mitogen-activated protein kinases and their roles in cepharanthine-induced apoptosis in human leukemia cells Cell Signal. 14 2002 509 515
9. M. Ono, N. Tanaka, and K. Orita Positive interactions between human interferon and cepharanthine against human cancer cells in vitro and in vivo Cancer Chemother. Pharmacol. 35 1994 10 16
10. A. Nakajima, Y. Yamamoto, K. Taura, K. Hata, M. Fukumoto, H. Uchinami, K. Yonezawa, and Y. Yamaoka Beneficial effect of cepharanthine on overcoming drug-resistance of hepatocellular carcinoma Int. J. Oncol. 24 2004 635 645
11. K. Nishikawa, J. Asaumi, S. Kawasaki, M. Kuroda, Y. Takeda, and Y. Hiraki Influence of cepharanthine on the intracellular accumulation of adriamycin in normal liver cells and spleen cells of mice in vitro and in vivo Anticancer Res. 17 1997 3617 3621
12. J. Raingeaud, S. Gupta, J.S. Rogers, M. Dickens, J. Han, R.J. Ulevitch, and R.J. Davis Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine J. Biol. Chem. 270 1995 7420 7426
13. Y.R. Chen, C.F. Meyer, and T.H. Tan Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis J. Biol. Chem. 271 1996 631 634
14. K.P. Sarker, K.K. Biswas, M. Yamakuchi, K.Y. Lee, T. Hashiguchi, M. Kracht, I. Kitajima, and I. Maruyama ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death J. Neurochem. 85 2003 50 61
15. S.G. Kennedy, A.J. Wagner, S.D. Conzen, J. Jordan, A. Bellacosa, P.N. Tsichlis, and N. Hay The PI3-kinase/Akt signaling pathway delivers an anti-apoptotic signal Genes Dev. 11 1997 701 713
16. K.K. Biswas, K.P. Sarker, K. Abeyama, K. Kawahara, S. Iino, Y. Otsubo, K. Saigo, H. Izumi, T. Hashiguchi, M. Yamakuchi, K. Yamaji, R. Endo, K. Suzuki, H. Imaizumi, and I. Maruyama Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis Hepatology 38 2003 1167 1177
17. K.P. Sarker, S. Obara, M. Nakata, I. Kitajima, and I. Maruyama Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3 FEBS Lett. 472 2000 39 44
18. A.H. Wyllie, G.J. Beattie, and A.D. Hargreaves Chromatin changes in apoptosis Histochem. J. 13 1981 681 692
19. Y.F. Shi, M.G. Szalay, L. Paskar, B.M. Sahai, M. Boyer, B. Singh, and D.R. Green Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation J. Immunol. 144 1990 3326 3333
20. T. Fujimura, S. Furusawa, H. Kawauchi, Y. Takayanagi, and K. Sasaki Effect of cepharanthine on doxorubicin cytotoxicity in P388 murine leukemia cells in vitro and in vivo Res. Commun. Chem. Pathol. Pharmacol. 71 1991 235 238
21. H. Akamatsu, J. Komura, Y. Asada, and Y. Niwa Effects of cepharanthine on neutrophil chemotaxis, phagocytosis, and reactive oxygen species generation J. Dermatol. 18 1991 643 648
22. S. Ghatan, S. Larner, Y. Kinoshita, M. Hetman, L. Patel, Z. Xia, R.J. Youle, and R.S. Morrison p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons J. Cell Biol. 150 2000 335 347
23. K.P. Sarker, K.K. Biswas, J.L. Rosales, K. Yamaji, T. Hashiguchi, and I. Maruyama Ebselen inhibits NO-induced apoptosis of differentiated PC12 cells via inhibition of ASK1-p38 MAPK-p53 and JNK signaling and activation of p44/42 MAPK and Bcl-2 J. Neurochem. 87 2003 1345 1353
24. C.L. Sutherland, A.W. Heath, S.L. Pelech, P.R. Young, and M.R. Gold Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor J. Immunol. 157 1996 3381 3390
25. R.Y. Liu, C. Fan, G. Liu, N.E. Olashaw, and K.S. Zuckerman Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-alpha-supported proliferation of leukemia and lymphoma cell lines J. Biol. Chem. 275 2000 21086 21093
26. M. Ameyar, A. Atfi, Z. Cai, R. Stancou, V. Shatrov, A. Bettaieb, and S. Chouaib Analysis of human breast adenocarcinoma MCF7 resistance to tumor necrosis factor-induced cell death. Lack of correlation between JNK activation and ceramide pathway J. Biol. Chem. 273 1998 29002 29008
27. O. Potapova, M. Gorospe, F. Bost, N.M. Dean, W.A. Gaarde, D. Mercola, and N.J. Holbrook c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells J. Biol. Chem. 275 2000 24767 24775
28. D. Javelaud, and F. Besancon NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B Oncogene 20 2001 4365 4372
29. H. Kamata, S. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases Cell 120 2005 649 661
30. X. Wang, J.L. Martindale, and N.J. Holbrook Requirement for ERK activation in cisplatin-induced apoptosis J. Biol. Chem. 275 2000 39435 39443
31. A. Kalmes, J. Deou, A.W. Clowes, and G. Daum Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580 FEBS Lett. 444 1999 71 74
32. J. Harada, and M. Sugimoto An inhibitor of p38 and JNK MAP kinases prevents activation of caspase and apoptosis of cultured cerebellar granule neurons Jpn. J. Pharmacol. 79 1999 369 378
33. S. Nemoto, J. Xiang, S. Huang, and A. Lin Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase J. Biol. Chem. 273 1998 16415 16420
34. S. Osone, H. Hosoi, Y. Kuwahara, Y. Matsumoto, T. Iehara, and T. Sugimoto Fenretinide induces sustained-activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species-dependent manner in neuroblastoma cells Int. J. Cancer 112 2004 219 224
35. J. Luo, Y. Sun, H. Lin, Y. Qian, Z. Li, S.S. Leonard, C. Huang, and X. Shi Activation of JNK by vanadate induces a Fas-associated death domain (FADD)-dependent death of cerebellar granule progenitors in vitro J. Biol. Chem. 278 2003 4542 4551
36. H. Aoki, P.M. Kang, J. Hampe, K. Yoshimura, T. Noma, M. Matsuzaki, and S. Izumo Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes J. Biol. Chem. 277 2002 10244 10250
37. A. Clerk, S.J. Fuller, A. Michael, and P.H. Sugden Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses J. Biol. Chem. 273 1998 7228 7234
38. T.K. Lee, K. Man, J.W. Ho, C.K. Sun, K.T. Ng, X.H. Wang, Y.C. Wong, I.O. Ng, R. Xu, and S.T. Fan FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation Carcinogenesis 25 2004 2397 2405
39. R.M. Kluck, E. Bossy-Wetzel, D.R. Green, and D.D. Newmeyer The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis Science 275 1997 1132 1136
40. P. Juo, C.J. Kuo, S.F. Reynolds, R.F. Konz, J. Raingeaud, R.J. Davis, J. Biemann, and H.M. Blenis Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases Mol. Cell. Biol. 17 1997 24 35
41. I. Ozaki, E. Tani, H. Ikemoto, H. Kitagawa, and H. Fujikawa Activation of stress-activated protein kinase/c-Jun NH2-terminal kinase and p38 kinase in calphostin C-induced apoptosis requires caspase-3-like proteases but is dispensable for cell death J. Biol. Chem. 274 1999 5310 5317
42. H. Seimiya, T. Mashima, M. Toho, and T. Tsuruo c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis J. Biol. Chem. 272 1997 4631 4636
43. K. Harada, T. Bando, H. Yoshida, and M. Sato Characteristics of antitumour activity of cepharanthine against a human adenosquamous cell carcinoma cell line Oral Oncol. 37 2001 643 651
44. H.J. Lee, C.J. Wang, H.C. Kuo, F.P. Chou, L.F. Jean, and T.H. Tseng Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK Toxicol. Appl. Pharmacol. 203 2005 124 128